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Objective: The present study aims to determine the culture & sensitivity pattern of bacteria in a stated cohort of patients at a 
Surgical Unit.  
Materials and Methods: This prospective cohort study was conducted over a period of 1-year duration at a tertiary-care-
Hospital. All patients presenting with diabetic foot who had not been subjected to empiric antibiotic therapy were enrolled. 
Demographic & lesion-based variables were studied and the Culture & Sensitivity pattern was evaluated and statistically 
analyzed.  
Results: 100 patients were included in the study, of which 80 were male (mean-age 60.8±12.7 years) & the rest female (mean-
age 58.4 ± 11.3 years). 35% of cultures yielded no growth. The remaining cases showed the following pathogens in descending 
order of incidence. Maximal sensitivity was also reported as mentioned. 1) Staphylococcus aureus & Klebsiella-Pneumoenae–
Piperacillin/Tazobactam, 2) Pseudomonas-Aerugionas-Cefotaxime, 3)E-coli–Amikacin& Sulbactam, 4) Proteus -Gentamicin, 
5) Streptococci– Amikacin and 6) Bacteroides – Cefoperazone & Aztreonam. Of 71 cases, 70 had aerobic-organisms isolates & 
only 1 had anaerobic-isolate. 
Conclusion: Six pathogens were identified in the present study of which Staphylococcus-Aureus was the most prevalent as 
well as the most resistant. Streptococci & Gram-negative Organisms were observed in the remaining cases. While the 
formulation of an adequate antibiotic regime is rendered difficult by resistance & mixed infections, targeted antibiotic 
administration is decisively crucial to achieving optimal & timely outcomes in the diabetic foot. 
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Introduction 
 
Diabetes mellitus is a disorder of sugar metabolism 
which is characterized by chronic hyperglycemia 
either due to insufficient insulin secretion (Type I), 
insulin insensitivity (Type II), or both.1 Side effect of 
diabetes can be devastating if not controlled. It has 
been postulated that hyperglycemia hinders proper 
wound healing. This is a result of advanced glycation 
end-products (AGEs) which amplify the production of 
inflammatory molecules like tumor necrosis factor and 
interleukin-1. These mediators interfere with the 
formation of collagen. Diabetic foot syndrome is a 
catastrophic condition in patients suffering from 
diabetes mellitus. It has a cumulative lifetime 
incidence that can be up to 25 percent.2 In diabetics, 
foot abnormalities result from peripheral neuropathy, 
macroangiopathy, and other aftermaths of metabolic 
disturbances. Patients usually present with foot ulcers 
and Charcot foot deformity, with many ending up 
with amputation of parts of the foot or part of the leg.3 
In diabetic patients, neuropathy predisposes them to 
an increased incidence of foot infections while 
angiopathy has a strong influence on their outcome. 
Other factors for infections and subsequent 
amputations are foot ulcer that remains unhealed, 
advancing age, male gender, and smoking. The timely 
detection and control of infections can avert this 
potentially dangerous situation and save many 
patients from impending amputations.4,5  
A variety of bacteria can infect the diabetic foot. The 
most frequently isolated organisms involved in 
diabetic foot ulcers include Staphylococcus aureus, 
Streptococcus pyogenes, Enterococci, and 
Pseudomonas aeruginosa. Many of these 
microorganisms have developed resistance to 
commonly used antibiotics.6 In one study conducted in 
Nigeria, bacterial cultures that were isolated from the 
ulcer base were all sensitive to quinolone antibiotics.7 
A similar study done in India found imipenem to be 
effective against the isolates.6 It is also suggested that 
contrary to the West, gram-negative bacteria 
dominated wound infections in the patients with 
diabetic foot infections in India. Polymicrobial 
multidrug-resistant gram-negative bacillus infections 
were also found commonly.8 Empirical broad-
spectrum antibiotic treatment is widely practiced to 
ameliorate diabetic foot infections and the selection of 
an appropriate antibiotic regimen is guided by the 
severity of the infection.9 In an era where 
microorganisms are getting increasingly resistant, 
targeted antimicrobial therapy for the treatment of 
ulcers in patients suffering from diabetes has become 
crucial.10 The present study was undertaken to 
determine the microbiology and the current 
antimicrobial sensitivity pattern of the bacteria 
isolated from the patients with infected diabetic foot 
ulcers presenting to our hospital. 
 
Materials and Methods 
 
The study was conducted at Surgical Unit I of Benazir 
Bhutto Hospital, Rawalpindi from April 2017 to 
September 2018. Patients presenting with a diabetic 
foot ulcer in the emergency or the out-patient 
departments, who were not on any empirical antibiotic 
therapy before the onset of symptoms, were included 
in the study. Patients with a prior history of surgery 
for diabetic foot and patients with foot ulcers, 
infection, and gangrene due to causes other than 
diabetes-like varicose veins, peripheral vascular 
disease, and lymphatic obstruction were excluded 
from the study.   
Patients were included in the study according to the 
non-probability consecutive sampling technique. Their 
demographic details and the site and the type of the 
lesion were documented. An appropriate sample for 
culture and sensitivity was collected by first removing 
any overlying necrotic debris from the ulcer site. This 
was accomplished by vigorously scrubbing the wound 
with saline-moistened sterile gauze. The sample was 
then collected, preferably, from the expressed pus. 
Both aerobic and anaerobic organisms were identified. 
Data were analyzed using the statistical package for 
social sciences (SPSS version 23). Mean and standard 
deviation was calculated for the continuous variables. 





One hundred patients were included in the study, out 
of which 80 (80%) were men (mean age 60.8 ± 12.7 
years) and 20 (20%) were women (mean age 58.4 ± 11.3 
years). Diabetic foot predominantly affected right foot 
in our cohort (76% vs. 22%). Most patients with 
diabetic foot did not have proper control of their 
diabetes and this was statistically significant (p=0.03). 
Other diabetic complications (neuropathy or 
angiopathy) coexisted in 36% of the patients (Table 1). 
In our study, the severity of diabetic foot was normally 
distributed with patients in grade II and III in 
abundance, cumulatively accounting for over 60% of 
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the patients whereas patients in grade IV and V 
accounted for only 32% and 6% of the patients. 
However, the incidence of coexisting diabetic 
complications like neuropathy, angiopathy, or both 
was significantly greater in patients with grade IV or V 
disease (p=0.018) (Table 2). The graphical 
representation in figure 1 shows the skewed incidence 
of diabetic complications in patients with severe 
disease (Figure 1).  
Staphylococcus aureus was the most resistant 
organism among all the isolates. However, 35% of 
cultures yielded no growth. Staphylococcus aureus & 
Klebsiella-Pneumoenae was resistant to 
Piperacillin/Tazobactam whereas Pseudomonas-
Aerugionas was resistant to Cefotaxime. E-coli 
demonstrated significant resistance to Amikacin& 
Sulbactam, and Proteus was not sensitive to 
Gentamicin. In Streptococci, Amikacin showed 
reduced efficacy. Similarly, Bacteroides was resistant 
to Cefoperazone & Aztreonam. Of 71 cases, 70 had 
aerobic-organisms isolates & only 1 had anaerobic-
isolate (Table 2). 
 
Table 1: Characteristics of the population with 
diabetic foot 
Parameters  P-value 
Gender Male (n=80)  0.35 
 Female (n=20) 
Age 65.6  ± 10.3 - 
Affected Feet Right foot (n=76) 0.018 
Left foot   (n=22) 
Both feet   (n=2) 
Surgical 
Procedure 
Wound debridement (n=62) 0.6 




Controlled Diabetes (n=24) 0.03 




None (n= 64) 0.23 
Neuropathy  (n=24) 
Angiopathy + Neuropathy (n= 
12) 
 
Table 2: Comparison of severity of diabetic foot with 
other diabetic complications 
Grade  Presence of other 
diabetic 
complications 
No other diabetic 
complications 
I (n=2) - 2 
II (n=46) 2 44 
III (n=14) 1 13 
IV (n=32) 28 4 




Figure: 1 Comparison of diabetic foot severity with 
other diabetic complications 
 
 
Table 3: Resistance profile of the cultured bacteria 
Sr 
No. 

















1 Amikacin  24.3% 27.2% 71.4% 83.3% 33.3% 50% 0 0.02 
2 Salbactam 12.1% 9% 0 83.3% 0 0 0 0.01 
3 Gentamicin  19.5% 45.5% 42.8% 50% 66.6% 0 0 0.9 
4 Pipercillin/ 
Tazobactam 
95.1% 54.5% 71.4% 50% 0 0 0 0.001 
5 Aztreonam 63.4% 18.1% 28.5% 50% 0 0 100% 0.02 
6 Amoxicillin/ 
Clavulanate 
78% 9% 0 33.3% 0 0 0 0.4 
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7 Cefoperazon
e 
31.7% 9% 57.1% 33.3% 0 0 100% 0.2 
8 Cefotaxime 24.3% 9% 85.7% 33.3% 0 0 0 0.1 




In a study conducted in Postgraduate Medical 
Institute, Peshawar, in 2011, one hundred and four 
disease-causing microbes were cultured from ulcer 
bases. These cultures were isolated after wound 
debridement. The commonest pathogens that were 
cultured in the lab were Staphylococcus aureus (52, 
46%). E. coli (11,10%) was the second most common 
microorganism in the culture. MRSA (10 cases 9%) was 
also isolated. Streptococcus (65%) and Pseudomonas 
(54%) cultures were also seen in this study. A few 
specimens contained polymicrobial infection as well. 
The commonest antibiotics against these microbes 
were cefoperazone/sulbactam in (n=43) 38% of the 
cases. This was used alone or in combination with 
other antibiotics. This was followed by ceftriaxone in 
(n=36) 33% of the case. MRSA was treated by 
Linezolid in the case study. 82% (n=94) of the patients 
responded to antibiotic therapy. These patients were 
labeled as cured in the study.11 
In our study, culture reports for 35% of the patients 
showed no growth although only those patients were 
included in the study who had not received any 
antibiotics for 48 hours, before taking specimen for 
culture from deep abscesses and shifting it to the 
laboratory immediately. This could be related to a high 
incidence of self-medication with empirical antibiotics 
among the general population, laboratory error, or 
fungal infections.12 
 The organisms most commonly causing foot infections 
are Staphylococcus aureus and Streptococcus 
pyogenes suggesting that these organisms are 
probably part of the patient’s flora of the skin, while 
the anaerobes, the enterococci, and the coliforms are 
probably part of the patient’s gut flora. Due to this, the 
issue of differentiating colonization from infection 
remains, even when the specimen is properly 
collected.13 Also, similar studies performed in the past 
have always shown a complex polymicrobial 
microbiota in diabetic foot ulcers when compared to 
other wounds.14 These results suggest that the patient’s 
demographics and wound type are probably not 
linked to the microbiome of the chronic wound. 
Further research is needed to formulate a management 
plan according to a patient’s microbiota to improve 
wound healing.13 
In this study, about 90% of all staphylococcus 
organisms were resistant to penicillin antibiotics. 
These were treated with penicillinase-resistant 
penicillins such as flucloxacillin. 
In a study published in 2010, MRSA was a significant 
pathogen that was present in infected foot ulcers due 
to diabetes. It was estimated to be prevalent in 15–30% 
of the cases. This is an alarming situation that could 
cripple the healthcare system in many countries. 
Multiple studies have been published that have 
recognized the growing resistance of MRSA to 
vancomycin.15 
In our study, out of 71 positive culture reports, in 70 
cases had aerobic organisms were isolated while only 
one had an anaerobic causative organism which is 
comparable to other studies. 
Many disease-causing microbes cultured from diabetic 
foot infections are extremely resistant to regularly 
prescribed antibiotics. Hence, broad coverage of 
aerobic and anaerobic bacteria is necessary in these 
cases. Vascular impairment is a recognized 
complication in diabetes and it can affect the delivery 
of antibiotics to these tissues. This enhances the 
necessity and importance of drugs that can penetrate 
tissues extensively and even reach the bone.16 
Administration of ciprofloxacin or amoxicillin for two 
weeks demonstrated a remarkable result in treating 
diabetic foot infections in our study. 
Treatment for infected ulcers due to diabetes needs 
specific goals. The main target in such a condition is to 
eradicate all clinical evidence of microbial invasion 
and also to avoid soft tissue loss and amputation. 
Overall the clinical response is satisfactory (i.e. 
infection resolves to imperceptible levels) when 
appropriate therapy is utilized. However, some factors 
like sepsis, osteomyelitis, necrosis, gangrene, the 
proximal invasion of infection, peripheral arterial 
disease (PAD), chronic renal insufficiency, and dialysis 
are associated with a poor response to therapy and 
consequently, poor outcomes are inevitable in these 
scenarios.17 A study conducted in Pakistan linked male 
gender, age older than 50 years, residence in a rural 
area, and heel ulcers with poor outcomes in diabetic 
foot ulcers patients.18 
The current scenario for foot care in diabetes revolves 
around prevention. These strategies combine many 
different interventions that can reduce the risk of 
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infection and ulcer formation. These include patient 
education, proper skin, and nail care, and footwear 
that protects against trauma. Individualized and 
patient-specific foot care remains the most important 
element in a comprehensive program for the 
eradication of diabetic foot. Low-risk patients must 
wear non-constrictive footwear.19 The patient should 
be instructed to seek urgent medical attention once 
signs of deterioration appear. Increasing blood sugar 
and insulin requirement indicate early infection. An 
integrated approach to focus on the prevention of 
recurrence of foot ulcers in these patients must also be 
formulated. These strategies include strict and regular 
diabetes control, professional care of foot in diabetics 
at intervals of 1 to 3 months, proper footwear, and 
assessment of temperature of the foot to monitor 
inflammatory signs and intervention to ameliorate 
PAD. Early detection and treatment of new lesions 
(e.g. calluses) are also critical in avoiding 
complications.20 Morbidity and mortality due to the 
diabetic foot can be lowered only if the utmost 




Gram-positive and gram-negative aerobes were the 
most commonly isolated organisms. The problem of 
widespread antibiotic resistance and polymicrobial 
infections makes the formulation of adequate 
antibiotic therapy for managing and caring for diabetic 
ulcers on the foot difficult. Therefore, proper 
administration of antibiotics according to the isolated 
organisms, prompt surgical treatment for extensive 
involvement of the foot, and an aggressive 
multidisciplinary approach is warranted to manage 
not only the foot problems in the diabetic patients but 
also to recognize and reduce mortality from other co-
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